TSC1 Protein — Hamartin
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TSC1 Protein — Hamartin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Hamartin (TSC1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[TSC1](/genes/tsc1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UMX0](https://www.uniprot.org/uniprot/Q9UMX0)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~130 kDa (1164 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, lysosomes, endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TSC family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TSC1, Hamartin, KCAA0025</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous; highest in brain, heart, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">146 edges</a></td>
</tr>
</table>
...
TSC1 Protein — Hamartin
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TSC1 Protein — Hamartin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Hamartin (TSC1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[TSC1](/genes/tsc1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UMX0](https://www.uniprot.org/uniprot/Q9UMX0)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~130 kDa (1164 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, lysosomes, endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TSC family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TSC1, Hamartin, KCAA0025</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous; highest in brain, heart, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">146 edges</a></td>
</tr>
</table>
TSC1 (Hamartin) is a tumor suppressor protein that forms a critical complex with TSC2 (tuberin) to regulate the [mTORC1](/proteins/mtorc1-protein) signaling pathway. The TSC1-TSC2 complex acts as a GTPase-activating protein (GAP) for [Rheb](/proteins/rheb-protein), controlling the activation of mTORC1 and downstream anabolic processes including protein synthesis, lipid metabolism, and autophagy. In the nervous system, proper TSC1 function is essential for neuronal morphology, synaptic plasticity, and cellular homeostasis. Dysregulation of TSC1-mTOR signaling has been implicated in [Tuberous Sclerosis Complex](/diseases/tuberous-sclerosis), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [epilepsy](/diseases/epilepsy).
:: infobox .infobox-protein
::
Overview
The TSC1-TSC2 complex is a central regulator of cellular anabolic metabolism through its control of mTORC1 signaling. TSC1 (hamartin) and TSC2 (tuberin) form a heterodimeric complex that localizes primarily to the cytoplasm and lysosomal membranes, where it senses cellular nutrient, energy, and growth factor status.
The core function of the TSC1-TSC2 complex is:
Rheb GAP Activity: TSC2 has intrinsic GAP activity toward [Rheb](/proteins/rheb-protein), converting active Rheb-GTP to inactive Rheb-GDP
mTORC1 Inhibition: Inactive Rheb cannot activate mTORC1, thereby inhibiting protein synthesis and other anabolic processes
Nutrient Sensing: The TSC1-TSC2 complex integrates signals from multiple pathways including [AMPK](/proteins/ampk-protein), [AKT](/proteins/akt1-protein), and [ERK](/proteins/erk-protein)
Autophagy Regulation: TSC1-TSC2 controls autophagy through mTORC1-dependent and independent mechanismsIn neurons, TSC1-mTOR signaling regulates:
- Synaptic Plasticity: Local protein synthesis at synapses is controlled by mTORC1 activity
- Neuronal Morphogenesis: mTORC1 controls dendritic arborization and axonal growth
- Cellular Homeostasis: Autophagy regulation maintains neuronal health
- Metabolism: Lipid and protein synthesis are balanced with degradation
Structure
TSC1 is a 1164-amino acid protein with a molecular weight of approximately 130 kDa. Key structural features include:
- N-terminal Hamartin Homology Domain: Mediates TSC1-TSC2 binding
- Coiled-coil Domains: Enable protein-protein interactions
- Tuberous Sclerosis Homology Domain: Mediates localization to lysosomes and endosomes
- C-terminal Domain: Interacts with signaling proteins
The structure of TSC1 is primarily alpha-helical, with multiple coiled-coil regions that mediate dimerization with TSC2. The TSC1-TSC2 interaction is stable, with both proteins required for proper cellular localization and function.
Normal Function
The TSC1-TSC2 complex is the functional unit:
Heterodimer Formation: TSC1 and TSC2 associate through their N-terminal coiled-coil domains
Complex Stability: TSC1 stabilizes TSC2, preventing its proteasomal degradation
Subcellular Localization: The complex localizes to lysosomes through interactions with the TSC1 C-terminus
Signal Integration: Multiple signaling pathways regulate the complexmTORC1 Regulation
The TSC1-TSC2 complex controls [mTORC1](/proteins/mtorc1-protein) through Rheb:
Rheb GAP Activity: TSC2's GAP domain converts Rheb-GTP to Rheb-GDP
mTORC1 Activation: Rheb-GTP directly activates mTORC1
Growth Factor Signaling: [AKT](/proteins/akt1-protein) phosphorylates and inhibits TSC2, promoting mTORC1 activation
Energy Sensing: [AMPK](/proteins/ampk-protein) activates TSC1-TSC2 during energy stress, inhibiting mTORC1Autophagy Regulation
The TSC1-TSC2 complex regulates [autophagy](/mechanisms/autophagy):
mTORC1-Dependent: mTORC1 inhibits autophagyinitiation through ULK1 phosphorylation
mTORC1-Independent: TSC1 can directly regulate autophagy components
Lysosomal Function: TSC1 localizes to lysosomes where autophagy occurs
Neuronal Autophagy: Neurons rely on basal autophagy for protein quality controlNeuronal Functions
In neurons, TSC1-mTOR signaling regulates:
Local Translation: mTORC1 localizes to dendritic spines for activity-dependent translation
Synaptic Plasticity: Long-term potentiation (LTP) and depression (LTD) require mTORC1 activity
Dendrite Morphogenesis: mTORC1 controls dendritic arbor complexity
Axon Guidance: Growth cone dynamics are regulated by TSC1-mTORRole in Disease
Tuberous Sclerosis Complex
[TSC](/diseases/tuberous-sclerosis) is caused by heterozygous TSC1 or TSC2 mutations:
Autosomal Dominant: Mutations in either TSC1 or TSC2 cause the disease
Hamartomas: Benign tumors grow in multiple organs including brain, skin, and kidneys
Neurological Symptoms: Epilepsy, intellectual disability, and autism are common
SEGAs: Subependymal giant cell astrocytomas are a serious complicationThe neurological manifestations of TSC reflect the essential role of TSC1 in neuronal development and function.
Alzheimer's Disease
TSC1-mTOR signaling is dysregulated in AD:
mTORC1 Hyperactivity: AD brains show increased mTORC1 activity despite decreased upstream signaling
Autophagy impairment: Autophagy is impaired in AD, with accumulated autophagic vacuoles
Synaptic Protein Synthesis: Dysregulated local translation may contribute to synaptic loss
Amyloid-β Effects: [Amyloid-β](/proteins/amyloid-beta) can alter TSC1-mTOR signalingTherapeutic strategies targeting mTORC1 in AD are under investigation, with rapamycin showing promise in preclinical models.
Parkinson's Disease
TSC1-mTOR signaling may be affected in [PD](/diseases/parkinsons-disease):
Alpha-Synuclein: mTORC1 regulates [alpha-synuclein](/proteins/alpha-synuclein) synthesis
Autophagy: PD is associated with autophagy deficits
Mitochondrial Dysfunction: mTORC1 regulates mitochondrial quality control
L-DOPA Response: Dysregulated mTORC1 may affect L-DOPA responseEpilepsy
TSC1 mutations cause epilepsy through multiple mechanisms:
Cortical Dysplasia: Abnormal neuronal migration in TSC
mTORC1 Hyperactivity: Excess mTORC1 activity causes hyperexcitability
Synaptic Dysfunction: Altered synaptic protein synthesis
mTOR Inhibitors: Rapamycin and related drugs reduce seizure frequencyTherapeutic Targeting
Current therapeutic strategies include:
mTOR Inhibitors: [Rapamycin](/proteins/rapamycin), [everolimus](/proteins/everolimus), and related rapalogs
Dual mTOR Inhibitors: [Torin1](/proteins/torin1) and [AZD8055](/proteins/azd8055) inhibit both mTORC1 and mTORC2
Autophagy Inducers: Trehalose and other autophagy-inducing compounds
Gene Therapy: TSC1 gene replacement is theoretically possibleRapamycin and everolimus are FDA-approved for TSC and have shown efficacy in reducing seizure frequency and tumor size.
Interacting Proteins
TSC1 interacts with:
- [TSC2 (Tuberin](/proteins/tsc2-protein)) — The TSC complex partner
- [Rheb](/proteins/rheb-protein) — GAP target
- [mTORC1](/proteins/mtorc1-protein) — Downstream effector
- [AMPK](/proteins/ampk-protein) — Energy sensor
- [AKT1](/proteins/akt1-protein) — Growth factor signaling
- [ERK1/2](/proteins/erk-protein) — MAPK signaling
- [ULK1](/proteins/ulkl1-protein) — Autophagy initiation
Key Publications
[Huang & Manning, The TSC1-TSC2 complex in mTOR (2003)](https://pubmed.ncbi.nlm.nih.gov/12773155/) — Classic review
[Kwiatkowski & Manning, Tuberous sclerosis (2005)](https://pubmed.ncbi.nlm.nih.gov/16077714/) — TSC pathogenesis
[Tschoner et al., TSC1 in neuronal morphology (2014)](https://pubmed.ncbi.nlm.nih.gov/24711541/) — Neural functions
[Zhang & Zhang, TSC1 and mTOR in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28102844/) — Neurodegeneration
[Curatolo & Moavero, TSC1 mutations in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31178756/) — Epilepsy in TSC
[Wang & Tang, TSC-mTOR in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32845176/) — AD connectionCross-Links
- [TSC1 Gene](/genes/tsc1) — Gene page
- [TSC2 Protein](/proteins/tsc2-protein) — Complex partner
- [mTORC1 Signaling](/mechanisms/mtor-signaling) — Pathway page
- [Tuberous Sclerosis](/diseases/tuberous-sclerosis) — Disease page
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page
- [Parkinson's Disease](/diseases/parkinsons-disease) — Disease page
- [Autophagy](/mechanisms/autophagy) — Pathway page
See Also
- [mTOR Inhibitors](/proteins/mtor-inhibitors) — Therapeutic agents
- [Rheb Protein](/proteins/rheb-protein) — GAP target
- [Epilepsy Mechanisms](/diseases/epilepsy)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neuronal Morphogenesis](/mechanisms/neuronal-morphogenesis)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy)
References
[Huang & Manning, The TSC1-TSC2 complex in mTOR (2003)](https://pubmed.ncbi.nlm.nih.gov/12773155/)
[Kwiatkowski & Manning, Tuberous sclerosis (2005)](https://pubmed.ncbi.nlm.nih.gov/16077714/)
[Tschoner et al., TSC1 in neuronal morphology (2014)](https://pubmed.ncbi.nlm.nih.gov/24711541/)
[Zhang & Zhang, TSC1 and mTOR in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28102844/)
[Curatolo & Moavero, TSC1 mutations in epilepsy (2019)](https://pubmed.ncbi.nlm.nih.gov/31178756/)
[Wang & Tang, TSC-mTOR in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32845176/)